holtzman neil (42 risultati)

Condizione: Very Good. 1st Ed. Former library copy. Pages intact with possible writing/highlighting. Binding strong with minor wear. Dust jackets/supplements may not be included. Includes library markings. Stock photo provided. Product includes identifying sticker. Better World Books: Buy Books. Do Good.

Condizione: Very Good. 1st Ed. Pages intact with possible writing/highlighting. Binding strong with minor wear. Dust jackets/supplements may not be included. Stock photo provided. Product includes identifying sticker. Better World Books: Buy Books. Do Good.

Condizione: Good. 1st Ed. Former library copy. Pages intact with minimal writing/highlighting. The binding may be loose and creased. Dust jackets/supplements are not included. Includes library markings. Stock photo provided. Product includes identifying sticker. Better World Books: Buy Books. Do Good.

Paperback. Condizione: Good. xiii + 303 pp. Crease on lower front corner. Inscription in ink on half-title page. book.

Paperback. Condizione: Good. Underlining and marginalia in beginning and end of book. Light cover and edge-wear. Lh.

Condizione: Good. Item in good condition and has highlighting/writing on text. Used texts may not contain supplemental items such as CDs, info-trac etc.

PAPERBACK. Condizione: Collectible; Fine. First Edition. This softcover book is square and tight. The pages are clean, with no markings or folds. The wrappers are bright with no damage to the points and no folds or creases to the spine. The condition is As New. Not ex-library. No remainder mark.

VG, unmarked, 6" x 9" Paperback; top edge price mark; owner's. name. xiii + 303 pp.

Paperback. Condizione: Good+. 1st Edition (Unstated). Johns Hopkins Series In Contemporary Medicine And Public Health; 303 pages; Ex-Library copy with usual identifiers. Light wear to cover edges. No writing on text pages or major defects.; - We offer free returns for any reason and respond promptly to all inquiries. Your order will be packaged with care and ship on the same or next business day. Buy with confidence.

gebundene Ausgabe. Condizione: Gut. 316 Seiten Der Erhaltungszustand des hier angebotenen Werks ist trotz seiner Bibliotheksnutzung sehr sauber. Es befindet sich neben dem Rückenschild lediglich ein Bibliotheksstempel im Buch; ordnungsgemäß entwidmet. In ENGLISCHER Sprache. Sprache: Englisch Gewicht in Gramm: 590.

Condizione: Good. This is an ex-library book and may have the usual library/used-book markings inside.This book has hardback covers. Clean from markings. In good all round condition. No dust jacket. Please note the Image in this listing is a stock photo and may not match the covers of the actual item,850grams, ISBN:9780309047982.

paperback. Condizione: Good. Connecting readers with great books since 1972! Used textbooks may not include companion materials such as access codes, etc. May have some wear or writing/highlighting. We ship orders daily and Customer Service is our top priority!

gut erh./ good condition, 304 S., paperback, kart. Aus der Bibliothek von Wolfgang Hien, Bremer Arbeitswissenschaftler und Soziologe. Gramm 600.

Paperback. Condizione: Good. some shelfwear/edgewear but still NICE! - may have remainder mark & previous owner's name Standard-sized.

Hardcover. Ex-libris stamp to front endpage and contents page, otherwise very good condition. No dust jacket. Part of the Progress in Medical Genetics New Series, Vol. 7. 260pp. ISBN 0444012540. 11436.

Condizione: As New. Unread book in perfect condition.

PAP. Condizione: New. New Book. Shipped from UK. Established seller since 2000.

Hardcover. Condizione: Brand New. 245 pages. 9.50x6.25x1.00 inches. In Stock.

Condizione: New.

Trade Paperback. Condizione: Like New. Billy Barnes (Cover Photo) (illustratore). Copyright © 1997. 100 pp. Clean, fresh copy with very minor shelf wear on front and back cover, crisp pages and clean text. Synopsis: "Two discussion meetings were held on the impact of advances in human gentics on health care. The project's objectives were to initiate an examination of health care and related problems arising from the use of human molecular genetics for diagnosis of genetic disorders; to identify particular areas of concern; to recommend actions through which foundations and other institutions could have a significant impact; and to disseminate the discussions and conclusions of these discussions. .This reportsynthesizes the discussions and findings of the two meetings. It contains recommendations that demand attention as we move inexorably further into the era of genetically informed medicine. ".

Hardcover. Condizione: New. 1st Edition. New Hardcover book and DJ. --Shrink Wrapped. Ships NEXT DAY (m-f) We provides tracking, guarantee and we give you the same customer service we would expect when "we" place an order. We strive to be your go to book supplier.

Paperback. Condizione: New. Despite remarkable progress, much remains unknown about the risks and benefits of genetic testing. No effective interventions are yet available to improve the outcome of most inherited diseases; negative test results might not rule out future occurrence of disease, and positive test results do not necessarily mean the disease will inevitably develop. In view of this uncertainty, the Working Group on Ethical, Legal, and Social Implications of Human Genome Research at the National Institutes of Health and Department of Energy created the Task Force on Genetic Testing. Comprising representatives of fifteen major stakeholders in genetic testing and five government agencies involved with testing, the task force was charged with reviewing genetic testing in the United States and making recommendations to ensure the development of safe and effective genetic tests. In Promoting Safe and Effective Genetic Testing in the United States the members of this task force present the conclusions of their study. They begin by describing general principles involved in genetic testing, including informed consent, testing of children, confidentiality, and discrimination.They describe methods and policies to ensure the safety and effectiveness of new genetic tests, including criteria for developing tests and ways of ensuring compliance with those criteria. They then discuss how to ensure the quality of laboratories that perform genetic tests, including the role of laboratory personnel and methods of monitoring laboratory performance. They show how health care professionals outside the field of genetics can better understand the uses of genetic testing, and offer suggestions for changes in these professionals' education and training. Finally, they offer a look at testing for rare inherited genetic disorders. Members of the Task Force: Neil A. Holtzman, M.D., M.P.H. * Michael S. Watson, Ph.D., F.A.C.M.G. * Patricia A. Barr * David R. Cox, M.D., M.P.H. * Jessica G. Davis, M.D. * Stephen I. Goodman, M.D., M.Sc. * Wayne W. Grody, M.D., Ph.D. * Arthur L. Levin, M.D. * J. Alexander Lowden, M.D., Ph.D. * Patricia D. Murphy, Ph.D. * Patricia J. Numan, M.D. * Victoria O. Odesina, R.N., Sc.M., M.S. * Nancy Press, Ph.D. * Katherine A. Schneider, M.P.H. * David B. Singer * Steven Gutman, M.D., * Muin J. Khoury, M.D., Ph.D. * David Lanier, M.D. * Linda R.Lebovic * Jane S. Lin-Fu, M.D.

Condizione: New.

Paperback. Condizione: New. Despite remarkable progress, much remains unknown about the risks and benefits of genetic testing. No effective interventions are yet available to improve the outcome of most inherited diseases; negative test results might not rule out future occurrence of disease, and positive test results do not necessarily mean the disease will inevitably develop. In view of this uncertainty, the Working Group on Ethical, Legal, and Social Implications of Human Genome Research at the National Institutes of Health and Department of Energy created the Task Force on Genetic Testing. Comprising representatives of fifteen major stakeholders in genetic testing and five government agencies involved with testing, the task force was charged with reviewing genetic testing in the United States and making recommendations to ensure the development of safe and effective genetic tests. In Promoting Safe and Effective Genetic Testing in the United States the members of this task force present the conclusions of their study. They begin by describing general principles involved in genetic testing, including informed consent, testing of children, confidentiality, and discrimination.They describe methods and policies to ensure the safety and effectiveness of new genetic tests, including criteria for developing tests and ways of ensuring compliance with those criteria. They then discuss how to ensure the quality of laboratories that perform genetic tests, including the role of laboratory personnel and methods of monitoring laboratory performance. They show how health care professionals outside the field of genetics can better understand the uses of genetic testing, and offer suggestions for changes in these professionals' education and training. Finally, they offer a look at testing for rare inherited genetic disorders. Members of the Task Force: Neil A. Holtzman, M.D., M.P.H. * Michael S. Watson, Ph.D., F.A.C.M.G. * Patricia A. Barr * David R. Cox, M.D., M.P.H. * Jessica G. Davis, M.D. * Stephen I. Goodman, M.D., M.Sc. * Wayne W. Grody, M.D., Ph.D. * Arthur L. Levin, M.D. * J. Alexander Lowden, M.D., Ph.D. * Patricia D. Murphy, Ph.D. * Patricia J. Numan, M.D. * Victoria O. Odesina, R.N., Sc.M., M.S. * Nancy Press, Ph.D. * Katherine A. Schneider, M.P.H. * David B. Singer * Steven Gutman, M.D., * Muin J. Khoury, M.D., Ph.D. * David Lanier, M.D. * Linda R.Lebovic * Jane S. Lin-Fu, M.D.

Paperback. Condizione: new. Paperback. Despite remarkable progress, much remains unknown about the risks and benefits of genetic testing. No effective interventions are yet available to improve the outcome of most inherited diseases; negative test results might not rule out future occurrence of disease, and positive test results do not necessarily mean the disease will inevitably develop. In view of this uncertainty, the Working Group on Ethical, Legal, and Social Implications of Human Genome Research at the National Institutes of Health and Department of Energy created the Task Force on Genetic Testing. Comprising representatives of fifteen major stakeholders in genetic testing and five government agencies involved with testing, the task force was charged with reviewing genetic testing in the United States and making recommendations to ensure the development of safe and effective genetic tests. In Promoting Safe and Effective Genetic Testing in the United States the members of this task force present the conclusions of their study. They begin by describing general principles involved in genetic testing, including informed consent, testing of children, confidentiality, and discrimination.They describe methods and policies to ensure the safety and effectiveness of new genetic tests, including criteria for developing tests and ways of ensuring compliance with those criteria. They then discuss how to ensure the quality of laboratories that perform genetic tests, including the role of laboratory personnel and methods of monitoring laboratory performance. They show how health care professionals outside the field of genetics can better understand the uses of genetic testing, and offer suggestions for changes in these professionals' education and training. Finally, they offer a look at testing for rare inherited genetic disorders. Members of the Task Force: Neil A. Holtzman, M.D., M.P.H. * Michael S. Watson, Ph.D., F.A.C.M.G. * Patricia A. Barr * David R. Cox, M.D., M.P.H. * Jessica G. Davis, M.D. * Stephen I. Goodman, M.D., M.Sc. * Wayne W. Grody, M.D., Ph.D. * Arthur L. Levin, M.D. * J. Alexander Lowden, M.D., Ph.D. * Patricia D. Murphy, Ph.D. * Patricia J. Numan, M.D. * Victoria O. Odesina, R.N., Sc.M., M.S. * Nancy Press, Ph.D. * Katherine A. Schneider, M.P.H. * David B. Singer * Steven Gutman, M.D., * Muin J. Khoury, M.D., Ph.D. * David Lanier, M.D. * Linda R.Lebovic * Jane S. Lin-Fu, M.D. Despite remarkable progress, much remains unknown about the risks and benefits of genetic testing. No effective interventions are yet available to improve the outcome of most inherited diseases; negative test results might not rule out future occurrence of disease, and positive test results do not necessarily mean the disease will inevitably develop. In view of this uncertainty, the Working Group on Ethical, Legal, and Social Implications of Human Genome Research at the National Institutes of Health and Department of Energy created the Task Force on Genetic Testing. Comprising representatives of fifteen major stakeholders in genetic testing and five government agencies involved with testing, the task force was charged with reviewing genetic testing in the United States and making recommendations to ensure the development of safe and effective genetic tests. In Promoting Safe and Effective Genetic Testing in the United States the members of this task force present the conclusions of their study. They begin by describing general principles involved in genetic testing, including informed consent, testing of children, confidentiality, and discrimination. They describe methods and policies to ensure the safety and effectiveness of new genetic tests, including criteria for developing tests and ways of ensuring compliance with those criteria. They then discuss how to ensure the quality of laboratories that perform genetic tests, including the role of laboratory personnel and met Shipping may be from multiple locations in the US or from the UK, depending on stock availability.

Hardcover. 352 p. Very good condition. Reading pages are very clean and without marks. Retired library exemplar, with the usual marking. Minimal signs of storage and use. Still very good copy. 9780309047982 Sprache: Englisch Gewicht in Gramm: 581.

Paperback / softback. Condizione: New. New copy - Usually dispatched within 4 working days.

Condizione: As New. Unread book in perfect condition.

Condizione: New. In.

Paperback. Condizione: Brand New. 1st edition. 186 pages. 11.25x9.00x0.75 inches. In Stock.